Cancer Health Treatment Update mRNA COVID-19 Vaccines are Safe for People with Cancer The largest peer-reviewed study of the Pfizer-BioNTech COVID vaccine in cancer patients finds no more, and no different, side effects. CAR-T Immunotherapy Keeps Cancer in Remission for 10 Years The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured. Too Much Sitting Can Shorten Life for Cancer Survivors Lack of physical activity and sitting more than eight hours a day was associated with a higher risk for death. New Link Discovered Between Gut Microbiome and Anti-Tumor Immunity In animal studies, introducing intestinal bacteria can promote anti-tumor immunity in the colon. Advertisement Cancer Immunotherapy Flushes HIV Out of Hiding Keytruda can activate T cells that harbor latent HIV, a possible step toward a functional cure. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed From Flavonoids to Foods: 40 Years of Cancer Prevention Progress ASCO and American Cancer Society Collaboration Empowers People with Cancer Information They Can Trust World Cancer Day: Closing the Gap Biden Supercharges His 2016 Cancer Moonshot Program Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed From Flavonoids to Foods: 40 Years of Cancer Prevention Progress ASCO and American Cancer Society Collaboration Empowers People with Cancer Information They Can Trust World Cancer Day: Closing the Gap Biden Supercharges His 2016 Cancer Moonshot Program Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: